Platelet reactivity and the identification of acute coronary syndromes in the emergency department

Journal of Thrombosis and Thrombolysis

Volumn 28, Issue 1, 2009, Pages 31-37

  Darling, Chad E ^a   Michelson, Alan D ^a   Volturo, Gregory A ^a   Przyklenk, Karin ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACS; Emergency medicine; Platelet function; Platelets; Risk stratification

Indexed keywords

ADENOSINE DIPHOSPHATE; CD31 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CREATINE KINASE; FIBRINOGEN; FIBRINOGEN RECEPTOR; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; TROPONIN I; VON WILLEBRAND FACTOR;

ACUTE CORONARY SYNDROME; CORONARY ARTERY THROMBOSIS; ELECTROCARDIOGRAM; EMERGENCY WARD; HEART MUSCLE NECROSIS; HEMOSTASIS; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SHEAR STRESS; THORAX PAIN; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; EMERGENCY MEDICAL SERVICES; HUMANS; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 67449110871     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0242-x     Document Type: Review

References (64)

1. Pope JH, Aufderheide TP, Ruthazer R et al (2000) Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 342:1163-1170. doi: 10.1056/NEJM200004203421603
2. Lee TH, Rouan GW, Weisberg MC et al (1987) Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 60:219-224. doi: 10.1016/ 0002-9149(87)90217-7
3. Rusnak RA, Stair TO, Hansen K et al (1989) Litigation against the emergency physician: Common features in cases of missed myocardial infarction. Ann Emerg Med 18:1029-1034. doi: 10.1016/ S0196-0644(89)80924-2
4. Katz DA, Williams GC, Brown RL et al (2005) Emergency physicians' fear of malpractice in evaluating patients with possible acute cardiac ischemia. Ann Emerg Med 46:525-533. doi: 10.1016/ j.annemergmed.2005.04.016
5. Nawar EW, Niska RW, Xu J (2007) National hospital ambulatory medical care survey: 2005 emergency department summary. Adv Data 386:1-32
6. Know the Facts, Get the Stats. American Heart Association, Dallas, TX (2007) http://www.americanheart.org/downloadable/heart/ 116861545709855-1041%20KnowTheFactsStats07_loRes.pdf
7. Fesmire FM, Percy RF, Wears RL et al (1989) Initial ECG in Q wave and non-Q wave myocardial infarction. Ann Emerg Med 18:741-746. doi: 10.1016/ S0196-0644(89)80007-1
8. Wu AH, Apple FS, Gibler WB et al (1999) National academy of clinical biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 45:1104-1121
9. Anderson JL, Adams CD, Antman EM, et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116:e148-e304. doi: 10.1161/ CIRCULATIONAHA.107.737312
10. Zalenski RJ, Rydman RJ, Ting S et al (1998) A national survey of emergency department chest pain centers in the United States. Am J Cardiol 81:1305-1309. doi: 10.1016/S0002-9149(98)00159-3
11. Selker HP, Beshansky JR, Griffith JL et al (1998) Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial. Ann Intern Med 129:845-855
12. Apple FS, Wu AH, Mair J et al (2005) Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51:810-824. doi: 10.1373/clinchem.2004.046292
13. Freedman JE (2005) Molecular regulation of platelet-dependent thrombosis. Circulation 112:2725-2734. doi: 10.1161/ CIRCULATIONAHA.104.494468
14. Andrews RK, Berndt MC (2004) Platelet physiology and thrombosis. Thromb Res 114:447-453. doi: 10.1016/j.thromres.2004.07.020
15. Hsu-Lin S, Berman CL, Furie BC et al (1984) A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets. J Biol Chem 259:9121-9126
16. Merten M, Thiagarajan P (2000) P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 102:1931-1936
17. Larsen E, Celi A, Gilbert GE et al (1989) PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59:305-312. doi: 10.1016/0092-8674(89)90292-4
18. Gurbel PA, Kereiakes DJ, Dalesandro MR et al (2000) Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department. Am Heart J 139:320-328
19. Serebruany VL, Levine DJ, Nair GV et al (2001) Usefulness of combining necrosis and platelet markers in triaging patients presenting with chest pain to the emergency department. J Thromb Thrombolysis 11:155-162. doi: 10.1023/A:1011280801335
20. Ikeda H, Takajo Y, Ichiki K et al (1995) Increased soluble form of P-selectin in patients with unstable angina. Circulation 92:1693-1696
21. Hollander JE, Muttreja MR, Dalesandro MR et al (1999) Risk stratification of emergency department patients with acute coronary syndromes using P-selectin. J Am Coll Cardiol 34:95-105. doi: 10.1016/ S0735-1097(99)00175-8
22. Linden MD, Furman MI, Frelinger AL III et al (2007) Indices of platelet activation and the stability of coronary artery disease. J Thromb Haemost 5:761-765. doi: 10.1111/j.1538-7836.2007.02462.x
23. Eschen O, Christensen JH, Toft E et al (2005) Soluble adhesion molecules and marine n-3 fatty acids in patients referred for coronary angiography. Atherosclerosis 180:327-331. doi: 10.1016/ j.atherosclerosis.2004.12.006
24. Murphy RT, Foley JB, Mulvihill N et al (2001) Impact of preexisting statin use on adhesion molecule expression in patients presenting with acute coronary syndromes. Am J Cardiol 87:446-448, A6
25. Gurbel PA, Kereiakes DJ, Serebruany VL (2000) Soluble P-selectin is not a surrogate marker for platelet P-selectin: Evidence from a multicenter chest pain study group. J Thromb Thrombolysis 10:15-22. doi: 10.1023/ A:1018738502654
26. Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227-1234. doi: 10.1038/nm1102-1227
27. Chakhtoura EY, Shamoon FE, Haft JI et al (2000) Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings. Am J Cardiol 86:835-839. doi: 10.1016/ S0002-9149(00)01102-4
28. Singh N, Gemmell CH, Daly PA et al (1995) Elevated platelet-derived microparticle levels during unstable angina. Can J Cardiol 11:1015-1021
29. Armitage RJ, Fanslow WC, Strockbine L et al (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357:80-82. doi: 10.1038/357080a0
30. Inwald DP, McDowall A, Peters MJ et al (2003) CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 92:1041-1048. doi: 10.1161/ 01.RES.0000070111.98158.6C
31. Mach F, Schonbeck U, Sukhova GK et al (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 94:1931-1936. doi: 10.1073/ pnas.94.5.1931
32. Karmann K, Hughes CC, Schechner J et al (1995) CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 92:4342-4346. doi: 10.1073/ pnas.92.10.4342
33. Mach F, Schonbeck U, Libby P (1998) CD40 signaling in vascular cells: A key role in atherosclerosis? Atherosclerosis 137(Suppl):S89-S95. doi: 10.1016/S0021-9150(97)00309-2
34. Lutgens E, Gorelik L, Daemen MJ et al (1999) Requirement for CD154 in the progression of atherosclerosis. Nat Med 5:1313-1316. doi: 10.1038/ 15271
35. Henn V, Steinbach S, Buchner K et al (2001) The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98:1047-1054. doi: 10.1182/ blood.V98.4.1047
36. Andre P, Prasad KS, Denis CV et al (2002) CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 8:247-252. doi: 10.1038/nm0302-247
37. Mach F, Schonbeck U, Bonnefoy JY et al (1997) Activation of monocyte/ macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor. Circulation 96:396-399
38. Heeschen C, Dimmeler S, Hamm CW et al (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348:1104-1111. doi: 10.1056/ NEJMoa022600
39. Varo N, de Lemos JA, Libby P et al (2003) Soluble CD40L: Risk prediction after acute coronary syndromes. Circulation 108:1049-1052. doi: 10.1161/ 01.CIR.0000088521.04017.13
40. Aukrust P, Muller F, Ueland T et al (1999) Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100:614-620
41. Lee Y, Lee WH, Lee SC et al (1999) CD40L activation in circulating platelets in patients with acute coronary syndrome. Cardiology 92:11-16. doi: 10.1159/000006940
42. Garlichs CD, Eskafi S, Raaz D et al (2001) Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 86:649-655. doi: 10.1136/heart.86.6.649
43. Varo N, Vicent D, Libby P et al (2003) Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: A novel target of thiazolidinediones. Circulation 107:2664-2669. doi: 10.1161/ 01.CIR.0000074043.46437.44
44. Garlichs CD, John S, Schmeisser A et al (2001) Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 104:2395-2400. doi: 10.1161/hc4501.099312
45. Newman PJ, Berndt MC, Gorski J et al (1990) PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219-1222. doi: 10.1126/science.1690453
46. Muller WA, Berman ME, Newman PJ et al (1992) A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J Exp Med 175:1401-1404. doi: 10.1084/jem.175.5.1401
47. Gearing AJ, Newman W (1993) Circulating adhesion molecules in disease. Immunol Today 14:506-512. doi: 10.1016/0167-5699(93)90267-O
48. Chen J, Lopez JA (2005) Interactions of platelets with subendothelium and endothelium. Microcirculation 12:235-246. doi: 10.1080/ 10739680590925484
49. Soeki T, Tamura Y, Shinohara H et al (2003) Increased soluble platelet/ endothelial cell adhesion molecule-1 in the early stages of acute coronary syndromes. Int J Cardiol 90:261-268. doi: 10.1016/ S0167-5273(02)00564-8
50. Serebruany VL, Murugesan SR, Pothula A et al (1999) Soluble PECAM-1, but not P-selectin, nor osteonectin identify acute myocardial infarction in patients presenting with chest pain. Cardiology 91:50-55. doi: 10.1159/ 000006876
51. Furman MI, Benoit SE, Barnard MR et al (1998) Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31:352-358. doi: 10.1016/S0735-1097(97)00510-X
52. Furman MI, Barnard MR, Krueger LA et al (2001) Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 38:1002-1006. doi: 10.1016/ S0735-1097(01)01485-1
53. Michelson AD, Barnard MR, Krueger LA et al (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104:1533-1537. doi: 10.1161/hc3801.095588
54. Ott I, Neumann FJ, Gawaz M et al (1996) Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 94:1239-1246
55. Neumann FJ, Marx N, Gawaz M et al (1997) Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 95:2387-2394
56. Francis JL (2007) Platelet function analyzer (PFA)-100. In: Michelson AD (ed) Platelets, 2nd edn. Elsevier/Academic Press, San Diego, pp 519-34
57. Frossard M, Fuchs I, Leitner JM et al (2004) Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 110:1392-1397. doi: 10.1161/01.CIR.0000141575.92958.9C
58. Sestito A, Sgueglia GA, Spinelli A et al (2006) Increased platelet reactivity in unstable angina patients is not related to C-reactive protein levels. Platelets 17:336-339. doi: 10.1080/09537100600759329
59. Darling CE, Volturo GA, Michelson AD et al (2008) Early point-of-care assessment of platelet reactivity may assist in the rapid identification of acute coronary syndromes in the emergency department. Acad Emerg Med 15:SUpp 1-181
60. Carr ME, Krishnaswami A, Martin EJ (2002) Platelet contractile force (PCF) and clot elastic modulus (CEM) are elevated in diabetic patients with chest pain. Diabet Med 19:862-866. doi: 10.1046/ j.1464-5491.2002.00834.x
61. Krishnaswami A, Carr ME Jr, Jesse RL et al (2002) Patients with coronary artery disease who present with chest pain have significantly elevated platelet contractile force and clot elastic modulus. Thromb Haemost 88:739-744
62. Foegh ML, Zhao Y, Madren L et al (1994) Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain. J Intern Med 235:153-161
63. Lorenz RL, Hamm CW, Riesner H et al (1990) A prospective study of the diagnostic value of urinary thromboxane in patients presenting with acute chest pain. J Intern Med 227:429-434
64. Michelson AD (2004) Platelet function testing in cardiovascular diseases. Circulation 110:e489-e493. doi: 10.1161/ 01.CIR.0000147228.29325.F9